A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

Medically reviewed by Jamin Brahmbhatt, MD The treatment of metastatic castration-resistant prostate cancer (mCRPC) involves ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

According to the Prostate Cancer Foundation ... These changing hormone levels might cause too much cell growth. Another idea focuses on the role of DHT, a hormone that’s critical in the ...

The first patient in a phase 2 clinical trial evaluating 67Cu-SAR-bisPSMA for patients with metastatic castration-resistant ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score ...

Auron will present data highlighting the activity of AUTX-703, its oral, potent and selective degrader targeting KAT2A/B in cell lines and patient derived organoid models (PDXO) of neuroendocrine ...